Show simple item record

Risk assessment in the distribution channels of pharmaceutical companies

dc.contributor.advisorMilisavljević, Stevan
dc.contributor.otherĆosić, Ilija
dc.contributor.otherMaksimović, Rado
dc.contributor.otherBrkljač, Nebojša
dc.contributor.otherĐapan, Marko
dc.contributor.otherMilisavljević, Stevan
dc.creatorGrujić, Jelena
dc.date.accessioned2021-10-04T09:37:46Z
dc.date.available2021-10-04T09:37:46Z
dc.date.issued2021-09-27
dc.identifier.urihttps://www.cris.uns.ac.rs/DownloadFileServlet/Disertacija162585529442261.pdf?controlNumber=(BISIS)117948&fileName=162585529442261.pdf&id=18017&source=NaRDuS&language=srsr
dc.identifier.urihttps://www.cris.uns.ac.rs/record.jsf?recordId=117948&source=NaRDuS&language=srsr
dc.identifier.urihttps://www.cris.uns.ac.rs/DownloadFileServlet/IzvestajKomisije162585631766146.pdf?controlNumber=(BISIS)117948&fileName=162585631766146.pdf&id=18020&source=NaRDuS&language=srsr
dc.identifier.urihttps://nardus.mpn.gov.rs/handle/123456789/18569
dc.description.abstractPredmet istraživanja ovog rada je proučavanje farmaceutskih kompanija i rizičnih faktora koji se pojavljuju prilikom distribucije lekova. Suština istraživanja je sagledavanje potencijalnih faktora rizika u poslovnim procesima farmaceutskih kompanija, kao i u njihovim distributivnim kanalima. Ovo istraživanje obuhvata stručnjake iz deset farmaceutskih kompanija koje posluju na teritoriji jugoistočne Evrope. Istraživanje rizika u farmaceutskim kompanijama ima za cilj održavanje otpornosti, ostvarivanje kvaliteta i kontinuiteta upravljanja distribucije lekova, efektivno i efikasno upravljanje promenama u okruženju farmaceutskih kompanija i održavanje fleksibilnosti prilikom uvođenja lekova na tržište. U radu će biti prikazane smernice za upravljanje faktorima rizika u distributivnim kanalima farmaceutskih kompanija.sr
dc.description.abstractThe subject of this paper is the study of pharmaceutical companies and the risk factors that occur during distribution of drugs. The essence of the study is to assess the potential risk factors in the business processes of pharmaceutical companies, as well as in their distribution channels. This research includes experts from ten pharmaceutical companies that operate in Southeast Europe. The study of risk in the pharmaceutical companies aims to maintain the resistance, providing high quality and continuity of management of distribution of drugs, effective and efficient management of changes in the environment of pharmaceutical companies and the maintenance of flexibility when introducing drugs to the market. The paper will present the guidelines for the management of risk factors in the distribution channels of pharmaceutical companies.en
dc.languagesr (latin script)
dc.publisherУниверзитет у Новом Саду, Факултет техничких наукаsr
dc.rightsopenAccessen
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceУниверзитет у Новом Садуsr
dc.subjectFaktori rizika, distributivni kanali, farmaceutske kompanijesr
dc.subjectRisk factor, distribution channels, pharmaceutical companiesen
dc.titleUpravljanje faktorima rizika u distributivnim kanalima farmaceutskih kompanijasr
dc.title.alternativeRisk assessment in the distribution channels of pharmaceutical companiesen
dc.typedoctoralThesissr
dc.rights.licenseBY-NC-ND
dc.identifier.fulltexthttp://nardus.mpn.gov.rs/bitstream/id/76511/Disertacija_11502.pdf
dc.identifier.fulltexthttp://nardus.mpn.gov.rs/bitstream/id/76512/Izvestaj_komisije_11502.pdf
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_nardus_18569


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

openAccess
Except where otherwise noted, this item's license is described as openAccess